According to the expression of these receptors, breast cancer is classified into the following subtypes: luminal A or B (ER-positive, PR-positive and high or low Ki67, respectively), luminal B HER2-positive (ER-positive, PR-positive, HER2-positive), HER2-positive and triple negative breast cancer (TNBC, ER-negative, PR-negative, HER2-negative) (87). Here, ERBB2 is linked to breast carcinoma.